Emcure Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE168P01015
  • NSEID: EMCURE
  • BSEID: 544210
INR
1,515.95
32.5 (2.19%)
BSENSE

Feb 06

BSE+NSE Vol: 99.4 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
2,363.48
2,269.82
2,100.54
2,116.25
1,962.63
2,001.98
1,815.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,363.48
2,269.82
2,100.54
2,116.25
1,962.63
2,001.98
1,815.14
Raw Material Cost
421.23
420.46
432.50
403.87
399.83
391.49
331.72
Purchase of Finished goods
560.11
625.17
550.48
571.86
428.93
502.30
380.15
(Increase) / Decrease In Stocks
-18.91
-156.10
-180.97
-83.62
-46.03
-105.12
-28.76
Employee Cost
387.33
384.62
393.47
373.37
366.93
355.59
350.40
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
520.97
520.20
488.28
448.36
458.36
476.85
445.32
Total Expenditure (Excl Depreciation)
1,870.73
1,794.35
1,683.76
1,713.84
1,608.02
1,621.11
1,478.82
Operating Profit (PBDIT) excl Other Income
492.75
475.47
416.78
402.41
354.61
380.87
336.32
Other Income
1.85
3.12
3.70
4.45
3.90
35.65
23.44
Operating Profit (PBDIT)
494.60
478.59
420.48
406.86
358.51
416.52
359.76
Interest
37.98
32.54
26.76
39.03
31.78
46.22
58.76
Exceptional Items
-38.15
0.00
-3.50
-10.38
0.00
0.00
0.00
Gross Profit (PBDT)
418.47
446.05
390.22
357.45
326.73
370.30
301.00
Depreciation
104.68
104.64
99.46
96.84
96.81
96.90
93.59
Profit Before Tax
313.79
341.42
290.76
260.61
229.92
273.41
207.41
Tax
82.42
90.05
75.97
63.38
73.83
71.86
54.82
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
231.37
251.37
214.79
197.24
156.09
201.55
152.59
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
231.37
251.37
214.79
197.24
156.09
201.55
152.59
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.83
7.91
7.84
8.28
2.37
6.98
8.51
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
230.54
243.46
206.95
188.96
153.72
194.57
144.08
Equity Capital
189.57
189.57
189.51
189.48
189.43
189.10
181.15
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
12.16
12.84
10.92
9.97
8.11
10.29
7.95
Diluted Earnings per share
12.16
12.85
10.92
9.97
8.12
10.23
7.95
Operating Profit Margin (Excl OI)
20.85%
20.95%
19.84%
19.02%
18.07%
19.02%
18.53%
Gross Profit Margin
17.71%
19.65%
18.58%
16.89%
16.65%
18.5%
16.58%
PAT Margin
9.79%
11.07%
10.23%
9.32%
7.95%
10.07%
8.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 4.13% vs 8.06% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -5.31% vs 17.64% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 3.63% vs 14.08% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is 16.72% vs 21.60% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Emcure Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
2,363.48
1,064.72
1,298.76
121.98%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,363.48
1,064.72
1,298.76
121.98%
Raw Material Cost
421.23
212.01
209.22
98.68%
Purchase of Finished goods
560.11
104.34
455.77
436.81%
(Increase) / Decrease In Stocks
-18.91
13.08
-31.99
-244.57%
Employee Cost
387.33
191.42
195.91
102.35%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
520.97
248.05
272.92
110.03%
Total Expenditure (Excl Depreciation)
1,870.73
768.90
1,101.83
143.30%
Operating Profit (PBDIT) excl Other Income
492.75
295.82
196.93
66.57%
Other Income
1.85
18.28
-16.43
-89.88%
Operating Profit (PBDIT)
494.60
314.10
180.50
57.47%
Interest
37.98
1.88
36.10
1,920.21%
Exceptional Items
-38.15
0.00
-38.15
Gross Profit (PBDT)
418.47
312.22
106.25
34.03%
Depreciation
104.68
45.35
59.33
130.83%
Profit Before Tax
313.79
266.87
46.92
17.58%
Tax
82.42
68.98
13.44
19.48%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
231.37
197.89
33.48
16.92%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
231.37
197.89
33.48
16.92%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.83
0.00
0.83
Other related items
0.00
0.00
0.00
Consolidated Net Profit
230.54
197.89
32.65
16.50%
Equity Capital
189.57
15.67
173.90
1,109.76%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
12.16
12.63
-0.47
-3.72%
Diluted Earnings per share
12.16
12.45
-0.29
-2.33%
Operating Profit Margin (Excl OI)
20.85%
27.78%
0.00
-6.93%
Gross Profit Margin
17.71%
29.32%
0.00
-11.61%
PAT Margin
9.79%
18.59%
0.00
-8.80%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,363.48 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 4.13% vs 8.06% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 20.42% vs 17.69% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 230.54 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -5.31% vs 17.64% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 49.97% vs 35.50% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 492.75 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 3.63% vs 14.08% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 38.96% vs 20.73% in Dec 2024

Quarterly - Interest
Interest 37.98 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 16.72% vs 21.60% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 19.51% vs -47.60% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.85%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024